KALA BIO, Inc. (KALA) vs Senti Biosciences, Inc. (SNTI)

KALA BIO, Inc. and Senti Biosciences, Inc. are both Biotechnology companies. KALA BIO, Inc. and Senti Biosciences, Inc. are of similar size ($10.7M and $10.0M). KALA BIO, Inc. grew revenue faster over the last twelve months: −50.5% against −70.7%. KALA BIO, Inc. has the higher net margin (0.00% vs −3,789.3%) and the lower return on invested capital (−722.7% vs 0.00%). Across the 15 metrics below, KALA BIO, Inc. leads on 9 and Senti Biosciences, Inc. on 6.

Valuation

Metric KALA SNTI Biotechnology median
P/E n/m n/m 7.88
P/S 0.01 7.86 11.47
P/B 0.00 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 7.52 2.94 10.73
Earnings yield (6,658.33%) (536.36%) (28.84%)
Free cash flow yield (56,050.65%) (369.11%) (23.03%)

Profitability

Metric KALA SNTI Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (4,181.12%) 0.00%
Net margin 0.00% (3,789.30%) 0.00%
Free cash flow margin 0.00% (2,900.38%) 0.00%
Return on equity (345.32%) (466.46%) (57.72%)
Return on assets (43.23%) (97.52%) (49.22%)
Return on invested capital (722.69%) 0.00% 0.00%

Growth

Metric KALA SNTI Biotechnology median
Revenue growth (TTM) (50.54%) (70.73%) 5.64%
EPS growth (last fiscal year) 67.39% 77.31% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric KALA SNTI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.88 0.83 4.73
Net debt to EBITDA 0.19 0.25 0.96

Dividend

Metric KALA SNTI Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric KALA SNTI Biotechnology median
Market cap 10.73m 9.96m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack